TrialTrials2022

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).

Seonaidh Cotton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.